Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options

World Journal of Hepatology

Volumn 8, Issue 2, 2016, Pages 107-116

  Pozzato, Gabriele ^a   Mazzaro, Cesare ^b   Dal Maso, Luigino ^b   Mauro, Endri ^c   Zorat, Francesca ^a   Moratelli, Giulia ^a   Bulian, Pietro ^b   Serraino, Diego ^b   Gattei, Valter ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c Pordenone General Hospital   (Italy)

Author keywords

Alpha interferon; Hepatitis C virus; Hepatitis C virus genotypes; Non Hodgkin's lymphoma

Indexed keywords

EID: 84954421809     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v8.i2.107     Document Type: Review

References (98)

1. Vereide D, Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Semin Cancer Biol 2009; 19: 389-393 [PMID: 19628040 DOI: 10.1016/j.semcancer.2009.07.006]
2. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol 2000; 18: 3707-3721 [PMID: 11054444]
3. Kennedy G, Komano J, Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci USA 2003; 100: 14269-14274 [PMID: 14603034 DOI: 10.1073/pnas.2336099100]
4. Gallo RC. Research and discovery of the first human cancer virus, HTLV-1. Best Pract Res Clin Haematol 2011; 24: 559-565 [PMID: 22127321 DOI: 10.1016/j.beha.2011.09.012]
5. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571-573 [PMID: 6981847]
6. Cai Q, Verma SC, Lu J, Robertson ES. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 2010; 78: 87-142 [PMID: 21040832 DOI: 10.1016/B978-0-12-385032-4.00003-3]
7. Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 2010; 289: 140-150 [PMID: 19651473]
8. Leroy S, Moshous D, Cassar O, Reguerre Y, Byun M, Pedergnana V, Canioni D, Gessain A, Oksenhendler E, Fieschi C, Mahlaoui N, Rivière JP, Herbigneaux RM, Muszlak M, Arnaud JP, Fischer A, Picard C, Blanche S, Plancoulaine S, Casanova JL. Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review. Pediatrics 2012; 129: e199-e203 [PMID: 22157133 DOI: 10.1542/peds.2010-2739]
9. Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 1992; 20: 29-34 [PMID: 1737623]
10. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122: 767-769 [PMID: 7717599 DOI: 10.7326/0003-4819-122-10-199505150-00006]
11. Brass V, Moradpour D, Blum HE. Molecular virology of hepatitis C virus (HCV): 2006 update. Int J Med Sci 2006; 3: 29-34 [PMID: 16614739]
12. Hollinger FB. NANBH viruses. In: Hollinger FB, Robinson WS, Purcell RH, Gerin JL, Ticehurst J. Viral hepatitis, biological and clinical features, specific diagnosis and prophylaxis. New York: Raven Press, 1991: 139-173
13. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000; 242: 55-84 [PMID: 10592656]
14. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, Gómez J. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994; 68: 3425-3436 [PMID: 8151804]
15. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-973 [PMID: 16149085 DOI: 10.1002/hep.20819]
16. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15: 382-386 [PMID: 1332999]
17. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trépo C, Inchauspé G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97: 845-851 [PMID: 8609243 DOI: 10.1172/JCI118485]
18. Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, Grando MG, Mazzaro C, Reitano M, Modolo ML, Martelli P, Spada A, Santini G. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 2000; 85: 356-361 [PMID: 10756359]
19. Cosserat J, Cacoub P, Blétry O. Immunological disorders in C virus chronic hepatitis. Nephrol Dial Transplant 1996; 11 Suppl 4: 31-35 [PMID: 8918749]
20. Andreone P, Gramenzi A, Cursaro C, Bernardi M, Zignego AL. Monoclonal gammopathy in patients with chronic hepatitis C virus infection. Blood 1996; 88: 1122 [PMID: 8704223]
21. Ganne-Carrie N, Medini A, Coderc E, Seror O, Christidis C, Grimbert S, Trinchet JC, Beaugrand M. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a casecontrol study. J Autoimmun 2000; 14: 189-193 [PMID: 10677250 DOI: 10.1006/jaut.1999.0360]
22. Ramos-Casals M, García-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, Sánchez-Tapias JM, Font J, Ingelmo M. Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001;80: 1-8 [PMID: 11204499]
23. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K, Matsuura Y, Miyamura T. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94: 233-236 [PMID: 8990191]
24. Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, Carrozzo M, Mori C, Giuberti T, Ferrari C, Missale G. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology 2002; 36: 1446-1452 [PMID: 12447871]
25. Silvestri F, Barillari G, Fanin R, Zaja F, Infanti L, Patriarca F, Baccarani M, Pipan C, Falasca E, Botta GA. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies. Blood 1996; 88: 1125-1126 [PMID: 8704227]
26. Santini GF, Crovatto M, Modolo ML, Martelli P, Silvia C, Mazzi G, Franzin F, Moretti M, Tulissi P, Pozzato G. Waldenström macroglobulinemia: a role of HCV infection? Blood 1993; 82: 2932 [PMID: 8219244]
27. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495 [PMID: 1383822 DOI: 10.1056/NEJM199211193272104]
28. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P. Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol 1991; 9: 621-624 [PMID: 1662567]
29. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577 [PMID: 1326246 DOI: 10.7326/0003-4819-117-7-573]
30. Ferri C, La Civita L, Longombardo G, Zignego AL. Hepatitis C virus and mixed cryoglobulinaemia. Br J Rheumatol 1994; 33: 301 [PMID: 7512423]
31. Mazzaro C, Tulissi P, Moretti M, Mazzoran L, Pussini E, Crovatto M, Santini GF, Pozzato G. Clinical and virological findings in mixed cryoglobulinaemia. J Intern Med 1995; 238: 153-160 [PMID: 7629483]
32. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF, Ruggiero G. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996; 28: 1-9 [PMID: 8743066]
33. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia-- a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-856 [PMID: 4956871]
34. Grey HM, Kohler PF. Cryoimmunoglobulins. Semin Hematol 1973;10: 87-112 [PMID: 4633223]
35. Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN. Clonal B cell expansions in patients with essential mixed cryoglobulinaemia. Clin Exp Immunol 1989; 76: 54-60 [PMID: 2786780]
36. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, Zanussi C. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 1983;70: 73-82 [PMID: 6408882]
37. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287-308 [PMID: 6996482]
38. Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, Gobbi M, Falini B, Bordin G, Pileri S. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988; 79: 20-25 [PMID: 3124457]
39. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301 [PMID: 8639788]
40. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550 [PMID: 8790157]
41. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis 2012; 55 Suppl 1: S10-S15 [PMID: 22715208 DOI: 10.1093/cid/cis361]
42. Ferri C, Caracciolo F, La Civita L, Monti M, Longombardo G, Greco F, Zignego AL. Hepatitis C virus infection and B-cell lymphomas. Eur J Cancer 1994; 30A: 1591-1592 [PMID: 7833125]
43. Ferri C, La Civita L, Caracciolo F, Zignego AL. Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA 1994; 272: 355-356 [PMID: 8028163 DOI: 10.1001/jama.1994.03520050033021]
44. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053 [PMID: 7949176]
45. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394 [PMID: 7803287]
46. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004; 111: 1-8 [PMID: 15185336 DOI: 10.1002/ijc.20205]
47. Gisbert JP, García-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S, Acevedo A, Borque MJ, Pajares JM, Fernández-Rañada JM, Moreno-Otero R. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Eur J Gastroenterol Hepatol 2004; 16: 135-138 [PMID: 15075985]
48. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 745-752 [PMID: 15471561 DOI: 10.1111/j.1349-7006.2004.tb03256.x]
49. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 2078-2085 [PMID: 17119031 DOI: 10.1158/1055-9965]
50. Flanagan MB, Sathanoori M, Surti U, Soma L, Swerdlow SH. Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens. Am J Clin Pathol 2008; 130: 620-627 [PMID: 18794056 DOI: 10.1309/H9AREV6E2JTMEC6J]
51. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019-5032 [PMID: 21300984 DOI: 10.1182/blood-2011-01-293050]
52. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006; 45: 197-203 [PMID: 16684579 DOI: 10.1016/j.jhep.2006.02.014]
53. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-2017 [PMID: 17488966 DOI: 10.1001/jama.297.18.2010]
54. IARC. Monographs on the Evaluation of carcinogenic risks to Humans Volume 100 Part B: A review of human carcinogens: Biological agents. IARC Press: Lyon, 2012. Available from: URL: http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B. pdf
55. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 2134-2146 [PMID: 12525648 DOI: 10.1128/JVI.77.3.2134-2146.2003]
56. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005; 102: 18544-18549 [PMID: 16339892 DOI: 10.1073/pnas.0509402102]
57. Franceschi S, Lise M, Trépo C, Berthillon P, Chuang SC, Nieters A, Travis RC, Vermeulen R, Overvad K, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Kaaks R, Becker N, Trichopoulou A, Lagiou P, Bamia C, Palli D, Sieri S, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Peeters PH, Rodríguez L, Barroso LL, Dorronsoro M, Sánchez MJ, Navarro C, Barricarte A, Regnér S, Borgquist S, Melin B, Hallmans G, Khaw KT, Wareham N, Rinaldi S, Hainaut P, Riboli E, Vineis P. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011; 20: 208-214 [PMID: 21098651 DOI: 10.1158/1055-9965.EPI-10-0889]
58. Gasparotto D, De Re V, Boiocchi M. Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 2002; 43: 747-751 [PMID: 12153160 DOI: 10.1080/10428190290016845]
59. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428 [PMID: 9312998 DOI: 10.7326/0003-4819-127-6-199709150-00002]
60. Khoury T, Chen S, Adar T, Jacob EO, Mizrahi M. Hepatitis C infection and lymphoproliferative disease: accidental comorbidities? World J Gastroenterol 2014; 20: 16197-16202 [PMID: 25473174 DOI: 10.3748/wjg.v20.i43.16197]
61. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999; 29: 543-547 [PMID: 9918933 DOI: 10.1002/hep.510290224]
62. Newkirk MM, Mageed RA, Jefferis R, Chen PP, Capra JD. Complete amino acid sequences of variable regions of two human IgM rheumatoid factors, BOR and KAS of the Wa idiotypic family, reveal restricted use of heavy and light chain variable and joining region gene segments. J Exp Med 1987; 166: 550-564 [PMID: 2439644]
63. Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, Efremov DG. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433-2442 [PMID: 9516143]
64. Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P, Cuoghi A, Torelli G. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C viruspositive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253-261 [PMID: 11438472 DOI: 10.1016/S0002-9440(10)61691-4]
65. Perotti M, Ghidoli N, Altara R, Diotti RA, Clementi N, De Marco D, Sassi M, Clementi M, Burioni R, Mancini N. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoimmun Rev 2008; 7: 468-472 [PMID: 18558364 DOI: 10.1016/j.autrev.2008.03.008]
66. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa GL, Laffi G, Gentilini P. T(14; 18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 474-479 [PMID: 10655273 DOI: 10.1002/hep.510310230]
67. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laffi G, Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-580 [PMID: 12353944 DOI: 10.7326/0003-4819-137-7-200210010-00008]
68. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe J. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112: 364-369 [PMID: 11167830 DOI: 10.1046/j.1365-2141.2001.02573.x]
69. Cooper C, Lester R, Thorlund K, Druyts E, El Khoury AC, Yaya S, Mills EJ. Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis. QJM 2013;106: 153-163 [PMID: 23159839 DOI: 10.1093/qjmed/hcs214]
70. Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, Morgan T, Saperstein S, Asghar A, Hauser P. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res 2013; 74: 57-63 [PMID: 23272989 DOI: 10.1016/j.jpsychores.2012.10.012]
71. Schäfer A, Scheurlen M, Kraus MR. [Managing psychiatric side effects of antiviral therapy in chronic hepatitis C]. Z Gastroenterol 2012;50: 1108-1113 [PMID: 23059806 DOI: 10.1055/s-0031-1281682]
72. Tran HA, Malcolm Reeves GE, Gibson R, Attia JR. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis. J Gastroenterol Hepatol 2009; 24: 1163-1168 [PMID: 19682190 DOI: 10.1111/j.1440-1746.2009.05874.x]
73. Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011; 11: 48-55 [PMID: 21821153 DOI: 10.1016/j.autrev.2011.07.005]
74. Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A, Tosi A, Cassi E. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. Haematologica 1997; 82: 38-42 [PMID: 9107080]
75. Takai S, Tsurumi H, Ando K, Kasahara S, Sawada M, Yamada T, Hara T, Fukuno K, Takahashi T, Oyama M, Onishi H, Tomita E, Takami T, Imawari M, Moriwaki H. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005; 74: 158-165 [PMID: 15654908 DOI: 10.1111/j.1600-0609.2004.00376.x]
76. Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M, Bonoldi E, Chilosi M, Viglio A, Lazzarino M, Pizzolo G, Rodeghiero F. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 2006; 17: 1434-1440 [PMID: 16766591 DOI: 10.1093/annonc/mdl131]
77. Tomita N, Kodama F, Takabayashi M, Kawano T, Yamaji S, Fujimaki K, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 1159-1164 [PMID: 12916868 DOI: 10.1080/1042819031000083055]
78. Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, Reyes F, Hermine O. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006; 24: 953-960 [PMID: 16418500 DOI: 10.1200/JCO.2005.01.5016]
79. Sève P, Renaudier P, Sasco AJ, Dumontet C, Salles G, Coiffier B, Zoulim F, Broussolle C, Trépo C. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol 2004; 16: 1361-1365 [PMID: 15618846]
80. Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94 [PMID: 12110736 DOI: 10.1056/NEJMoa013376]
81. Vallisa D, Bertè R, Rocca A, Civardi G, Giangregorio F, Ferrari B, Sbolli G, Cavanna L. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106: 556-560 [PMID: 10335728 DOI: 10.1016/S0002-9343(99)00069-8]
82. Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y, Podevin P, Bouscary D, Sogni P, Blanche P, Dreyfus F. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia 2004; 18: 1711-1716 [PMID: 15284859 DOI: 10.1038/sj.leu.2403443]
83. Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, Besson C, Varet B, Troussard X, Cacoub P, Hermine O. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-76 [PMID: 15353484 DOI: 10.1182/blood-2004-05-1711]
84. Patriarca F, Silvestri F, Fanin R, Zaja F, Sperotto A, Baccarani M. Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alphainterferon treatment. Br J Haematol 2001; 112: 370-372 [PMID: 11167831 DOI: 10.1046/j.1365-2141.2001.02571.x]
85. Mazzaro C, De Re V, Spina M, Dal Maso L, Festini G, Comar C, Tirelli U, Pozzato G. Pegylated-interferon plus ribavirin for HCVpositive indolent non-Hodgkin lymphomas. Br J Haematol 2009; 145: 255-257 [PMID: 19239472 DOI: 10.1111/j.1365-2141.2008.07565.x]
86. Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, Lazzaro A, Trabacchi E, Anselmi E, Arcari AL, Moroni C, Bertè R, Lazzarino M, Cavanna L. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005; 23: 468-473 [PMID: 15659492 DOI: 10.1200/JCO.2005.06.008]
87. Levine AM, Shimodaira S, Lai MM. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med 2003; 349: 2078-2079 [PMID: 14627800 DOI: 10.1056/NEJM200311203492121]
88. Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D' Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J Hepatol 2011; 3: 278-284 [PMID: 22125661 DOI: 10.4254/wjh.v3.i11.278]
89. Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. J Clin Gastroenterol 2004;38: 360-363 [PMID: 15087696]
90. Rodriguez-Torres M, Lawitz E, Kowdley KV, Nelson DR, Dejesus E, McHutchison JG, Cornpropst MT, Mader M, Albanis E, Jiang D, Hebner CM, Symonds WT, Berrey MM, Lalezari J. Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatmentnaïve patients with HCV genotype 1: a randomized, 28-day, doseranging trial. J Hepatol 2013; 58: 663-668 [PMID: 23183528 DOI: 10.1016/j.jhep.2012.11.018]
91. Jacobson IM, Dore GJ, Foster GR, Fried MW, Radu M, Rafalsky VV, Moroz L, Craxi A, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Scott J, Sinha R, Beumont-Mauviel M. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 2014; 384: 403-413 [PMID: 24907225 DOI: 10.1016/S0140-6736(14)60494-3]
92. Suzuki F, Toyota J, Ikeda K, Chayama K, Mochida S, Hayashi N, Ishikawa H, Miyagoshi H, Hu W, McPhee F, Hughes EA, Kumada H. A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection. Antivir Ther 2014; 19: 491-499 [PMID: 24451122 DOI: 10.3851/IMP2730]
93. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014; 370: 1889-1898 [PMID: 24725239 DOI: 10.1056/NEJMoa1402454]
94. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77: 2604-2613 [PMID: 8640712]
95. Moccia F, Tognoni E, Boccaccio P. The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection. Ann Ital Med Int 1999; 14: 288-293 [PMID: 10638021]
96. Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E, Incardona P, Brusamolino E, Passamonti F, Burcheri S, Schena C, Pascutto C, Cavanna L, Magrini U, Lazzarino M. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107-115 [PMID: 14692030 DOI: 10.1002/cncr.11893]
97. Pitini V, Arrigo C, Righi M, Scaffidi M, Sturniolo G. Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma. Br J Haematol 2004; 124: 252-253 [PMID: 14687039 DOI: 10.1046/j.1365-2141.2003.04751.x]
98. Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F, Merli M, Rattotti S, Rossi D, Riboni R, Berti E, Magrini U, Bruno R, Gaidano G, Lazzarino M. Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Ann Oncol 2010; 21: 1189-1195 [PMID: 19858084 DOI: 10.1093/annonc/mdp454]